Universitary Hospital Juan Ramón Jiménez
Huelva, 21005, Spain
NCT Number: NCT06338618
Hepatic steatosis is a disease that is becoming more common in our society; approximately 40% of the population suffers from non-alcoholic fatty liver. The beneficial effect of manual therapy for the treatment of viscera dysfunctions such as the stomach or colon is known. The objective of this study is to demonstrate the anti-inflammatory effects of visceral manual therapy in patients with metabolic liver disease associated with non-alcoholic fatty liver.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Huelva, 21005, Spain
Chronic liver diseases such as metabolic disease associated with nonalcoholic fatty liver lead to a stiff liver due to activation of hepatic stellate cells or portal fibroblasts into matrix-producing myofibroblasts. Congested livers tend to fibrosis, while the physiological forces that the liver receives during physical activity and deep breathing could have a beneficial effect on it, favoring physiological remodeling.
The importance of the mobility of the viscera for their proper functioning is known. Likewise, the beneficial effect of physical activity on the liver is known. This physical activity includes a component of applying pressure on the liver. These pressures are also exerted during the techniques described for manual liver treatment. Although there is some evidence about the effectiveness of these manual techniques for the treatment of pain situations, the effect they could have on liver parameters is unknown.
For all these reasons, we aim to know the effect of manual liver techniques on biochemical and mechanical sensitivity parameters in subjects with Metabolic Disease Associated with Non-Alcoholic Fatty Liver (NAFLD).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The liver treatment protocol consists of performing twelve visceral manual techniques in an approximate time of 30 minutes twice a week for 4 weeks
Time frame: Pre-intervention. Post-intervention 4 weeks
Decrease in the hepatic steatosis index
Time frame: Pre-intervention. Post-intervention 4 weeks
Decrease in the FIB-4 index
Time frame: Pre-intervention. Post-intervention 4 weeks
Decrease in the NAFLD-fibrosis index
Time frame: Pre-intervention. Post-intervention 4 weeks
Decrease in the HMA index
Time frame: Pre-intervention. Post-intervention. 4 weeks
Decrease in the TyG index
Time frame: Pre-intervention Post-intervention 4 weeks
Pressure pain threshold in face and neck tissues. PPT levels defined as the minimum necessary
Time frame: Pre-intervention. Post-intervention 4 weeks
Self-perceived pain intensity
University of Seville
Other
Manual Therapy Effects in Patients With Metabolic-associated Fatty Liver Disease
Acronym: OSTEO-EHMet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05909631
Digestive System Diseases, Fatty Liver
Sulaymaniyah, Sulaimanyah, Iraq
View Trial DetailsNCT06297434
Digestive System Diseases, Fatty Liver
Busan, South Korea
View Trial DetailsNCT02520609
Digestive System Diseases, Fatty Liver
Bethesda, Maryland, United States
View Trial DetailsNCT07730905
Blood-Borne Infections, Chronic Disease
Foshan, Guangdong, China
View Trial Details